Long-Read vs. Short-Read Sequencing: Which Should You Use?
The choice between long-read and short-read sequencing is one of the most consequential decisions a researcher makes when designing a genomics study. It affects what variants you can detect, what regions of the genome you can access, what your study costs, and how confidently you can interpret your results.
The honest answer is that neither method is universally better. Each is the right choice for specific applications. The wrong method for your question wastes budget and produces data that does not answer what you set out to ask.
This post lays out what each method does well, where each fails, and how to decide which is right for your study. It also covers a third option: long-read low-pass sequencing that changes the cost calculation researchers have historically used to default to short reads.
The Core Difference: Read Length
The fundamental distinction is in the length of the sequences each technology produces.
Short-read sequencing (Illumina is the dominant platform) generates reads of about 150 base pairs. The technology is mature, highly accurate at the per-base level, and supports very high throughput at relatively low cost per base.
Long-read sequencing generates reads thousands to tens of thousands of base pairs long. PacBio HiFi reads are typically 10,000 to 20,000 base pairs with per-base accuracy above 99.9%. Oxford Nanopore reads can be even longer but historically had lower per-base accuracy, though that gap has narrowed with newer chemistry.
Read length is not just a technical specification. It is the variable that determines what kinds of genomic features each technology can resolve.
What Short-Read Sequencing Does Well
Short-read sequencing is the right choice in several situations.
High-throughput SNP genotyping in accessible regions. When the question is about common single nucleotide variants in well-characterized parts of the genome, short reads handle it reliably and cheaply.
RNA-seq for gene expression. For standard differential expression analysis, short-read RNA-seq is mature, well-supported, and cost-effective.
Targeted sequencing. For applications where specific regions are captured and sequenced deeply — exome sequencing, panel sequencing, amplicon sequencing — short reads remain the standard.
Deep coverage of small genomes. Bacterial genomes, viral genomes, and similar small targets can be sequenced very deeply with short reads at low cost.
Studies where SVs are not relevant. If the research question does not involve structural variation, repetitive regions, or complex genomic features, short reads provide what is needed.
Short-read sequencing is also extremely well-documented. Bioinformatics tools are mature, reference datasets are abundant, and most labs already have workflows in place. For the right application, that infrastructure is a real advantage.
What Long-Read Sequencing Does Well
Long-read sequencing is the right choice when the research question involves any of the following.
Structural variant detection. Insertions, deletions, inversions, duplications, and translocations larger than 50 base pairs are visible in long-read data with base-pair breakpoint resolution. Short reads systematically miss these variants regardless of coverage depth.
Repetitive and complex genomic regions. Centromeres, telomeres, ampliconic regions, transposable elements, and other repeat-rich sequences cannot be resolved with short reads. Long reads span them in a single contiguous sequence.
Sex chromosomes. The hemizygosity, repeat content, and structural complexity of sex chromosomes make them difficult or impossible to genotype accurately with short reads. (See How to Sequence Sex Chromosomes Accurately for more detail.)
Polyploid species. Allotetraploid and hexaploid genomes contain homeologous chromosomes that short reads cannot distinguish reliably. Long reads map confidently to the correct subgenome. (See Why Can't Short-Read Sequencing Resolve Polyploid Genomes? for more detail.)
Reference genome assembly. De novo assembly of new reference genomes is now largely a long-read application. Short reads cannot assemble across repeats, leaving fragmented assemblies that need long-read data to finish.
Haplotype phasing. Long reads physically link variants on the same chromosome, allowing direct phasing without parental data or statistical inference.
Methylation detection. PacBio HiFi reads capture methylation information directly during sequencing, without requiring bisulfite conversion or separate library preparation.
Studies in non-model organisms. Species without well-annotated reference genomes benefit from long reads because the data supports both variant detection and reference improvement simultaneously.
Cost: The Comparison That Changed
For most of the past decade, the cost comparison was simple. Short-read sequencing was significantly cheaper per base, and that pricing advantage drove most population-scale studies to short-read methods regardless of what the science needed.
That comparison has shifted, primarily because of the rise of long-read low-pass sequencing (LRLP).
LRLP uses low coverage per sample (typically under 3X per haplotype) and multiplexes 48 to 96 samples per PacBio Revio sequencing cell. This brings per-sample cost into a range that is competitive with short-read low-pass sequencing for population studies, while preserving the resolution advantages of long reads.
The relevant cost comparison is no longer "long read vs. short read per base." It is "cost per useful variant detected for your specific application." When SVs, complex regions, and structural genomic features are included in what counts as useful, LRLP often produces a lower cost per insight than short-read methods at population scale.
In one published comparison using a 130-line peanut diversity panel, LRLP detected 27,942 variants compared to 2,483 with short-read low-pass sequencing on the same samples. The per-variant cost difference is substantial. (Lee et al. 2025, bioRxiv preprint)
For deep individual-level sequencing, short reads still hold a per-base cost advantage. For population-scale work, the calculus has changed.
A Decision Framework
The decision between long-read and short-read sequencing is best made by working through the specific characteristics of your study, not by defaulting to one method.
Choose short-read sequencing if:
You are studying common SNPs in accessible genomic regions
Your species has a high-quality reference genome and well-characterized variation
You are doing RNA-seq, targeted sequencing, or working with small genomes
SVs and complex regions are not relevant to your research question
Your lab already has short-read infrastructure and the study fits its capabilities
Choose long-read deep sequencing if:
You are assembling a new reference genome
You need the highest possible resolution for a small number of samples
You are studying complex regions, SVs, or methylation at the individual level
Budget allows for deep coverage of each sample
Choose long-read low-pass (LRLP) sequencing if:
You are sequencing populations rather than individuals
Your species is polyploid, has a complex genome, or lacks a high-quality reference
SVs, repetitive regions, or sex chromosomes are relevant to your research question
You have hit the limits of short-read low-pass sequencing or SNP arrays
You need population-scale data without sacrificing variant detection breadth
For most population genomics applications where short reads have historically been the default by cost, LRLP is now worth a serious look. The default is no longer obvious.
Hybrid Approaches
Some studies benefit from combining both methods. A common pattern is using long-read sequencing on a smaller number of samples to build a comprehensive reference or variant catalog, then using short-read sequencing on the larger cohort to scale up genotyping.
This approach has real advantages when budgets are constrained and an existing short-read cohort needs to be extended. It also has limitations: variants only detectable by long reads in the reference subset will not have short-read equivalents in the cohort, so cohort-wide analysis is still bounded by what short reads can detect.
For studies where the full variant spectrum matters at the cohort level, LRLP applied across the full population produces more uniform and analytically complete data than hybrid approaches.
Frequently Asked Questions
Is short-read sequencing becoming obsolete? No. Short-read sequencing remains the right method for many applications, particularly targeted sequencing, RNA-seq, deep individual-level genome sequencing where SVs are not a focus, and small-genome work. The shift is in population-scale whole genome studies, where LRLP increasingly outperforms short-read low-pass on cost per useful variant.
Can I just use deeper short-read coverage to get the same variant detection as long reads? No. Some classes of variation — structural variants, complex region variants, sex chromosome variants — are not detectable with short reads at any coverage. Read length is the limiting factor, not depth.
How accurate is long-read sequencing compared to short-read? PacBio HiFi reads achieve per-base accuracy above 99.9%, which is comparable to or better than short reads. Earlier long-read technologies had lower accuracy, which is part of why short reads dominated for so long. The accuracy gap is largely closed.
Can long-read and short-read data be combined in the same analysis? Yes, with appropriate statistical methods. Integrating the two data types is feasible and is an active area of methodology development.
What sample types work with long-read sequencing? Any sample that yields high molecular weight DNA. Highly degraded samples — old FFPE blocks, heavily fragmented DNA from extreme environmental samples — are not suitable for long-read sequencing and remain better served by short reads.
Is long-read sequencing slower? Per-run turnaround time is comparable. The major difference is workflow design: LRLP multiplexes many samples per cell, so a study completes in fewer runs than a comparable short-read project.
Which method has better bioinformatics support? Both are well-supported in 2026. Short-read tools are more mature simply because they have been in use longer, but long-read bioinformatics tools are stable, documented, and supported by major reference pipelines.
The Bottom Line
Long-read and short-read sequencing are not competing technologies for the same job. They are different tools optimized for different research questions.
For population-scale studies, polyploid species, complex genomic regions, structural variants, sex chromosomes, and non-model organisms, long-read sequencing, particularly in its low-pass form, is increasingly the better choice. For targeted sequencing, RNA-seq, deep individual-level work, and well-characterized SNP studies in accessible regions, short reads remain the right tool.
The right question to ask is not which method is better but instead which method is right for the data you need to answer your specific research question.
Not sure which method fits your study? Talk to one of our scientists; design of experiment consultation is included with every Veil project.
For more on LRLP specifically, see What Is Long-Read Low-Pass Sequencing?
